The mechanism of a Chinese herbal formula on cancer pain

中药复方治疗癌性疼痛的作用机制

• 批准号: 8293055
• 负责人: Ling Xu
• 金额: $ 5.51万
• 依托单位: UNIVERSITY OF MARYLAND BALTIMORE
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-07-01 至 2014-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8293055
• 关键词: Acupuncture procedure; Adverse effects; Agreement; Alkaline Phosphatase; Analgesics; Animals; Anti-Inflammatory Agents; Anti-inflammatory; Attenuated; Award; Basic Science; Behavioral; Biochemical; Biological Assay; Cancer Etiology; Cancer Pain Management; Cancer Patient; Carcinoma; China; Chinese Herbs; Chinese People; Chinese Traditional Medicine; Clinical; Clinical Research; Clinical Trials Design; Collaborations; Collagen Type I; Complementary Medicine; Data; Development; Disease; Drug usage; Enzyme-Linked Immunosorbent Assay; Female; Filament; Foundations; Fright; Funding; Gel; Grant; Health; Herb; Herbal Medicine; Histologic; Hospitals; Human; Hyperalgesia; Institutes; Integrative Medicine; Interdisciplinary Study; International; Investigation; Journals; Laboratories; Laos; Mainstreaming; Malignant Bone Neoplasm; Malignant Neoplasms; Malignant neoplasm of prostate; Maryland; Materia Medica; Measures; Mechanics; Medicine; Metastatic Carcinoma to the Bone; Metastatic Neoplasm to the Bone; Modeling; Monitor; Mus; Opioid; Osteoclasts; Osteogenesis; Outcome; Pain; Pain management; Paper; Patients; Persistent pain; Pilot Projects; Play; Preparation; Prevention; Publishing; Qi; Rattus; Reporting; Research; Research Personnel; Research Project Grants; Role; Safety; Scientific Evaluation; Series; Serum; Spinal Ganglia; Staining method; Stains; Stimulus; Symptoms; TRP channel; Thermal Hyperalgesias; Toxic effect; United States National Institutes of Health; Universities; Vanilloid; Withdrawal; allodynia; base; bone; bone metabolism; cancer pain; chemotherapy; crosslink; gastrointestinal; inflammatory pain; male; malignant breast neoplasm; medical schools; medical specialties; member; molecular marker; pain inhibition; parent grant; pre-clinical; professor; programs; public health relevance; pyridinoline; receptor; research study; spontaneous pain; success; tumor

DESCRIPTION (provided by applicant): the proposed international research study on mechanisims of a Chinese herbal formula on cancer pain is an extension of our ongoing parents grants funded by NIH, P01-AT002605 (9/2005 - 8/201010) and R21 AT 004113 (2/1/08 - 1/31/10). Dr. Lixing Lao, the PI is the project leader of the P01 study on acupuncture's mechanisms of action on persistent inflammatory pain and C0-I of the study on the effect of acupuncture on cancer-related pain. The proposed project will be performed in collaboration with Dr. Ling Xu at Changzheng Hospital (CZ), Shanghai, China. Pain, one of the most common and feared symptoms associated with cancer, is not yet adequately controlled. Chines herbal medicine has been used for thousands of years to treat a variety of ailments, including pain. Dr. Lao and his team have been undertaking investigations on carcionoma-induced pain, and his collaborator, Dr. Ling Xu has been investigating the effect of Traditional Chinese Medicine (TCM) on cancer-related disorders, including pain. Previous studies show that osteoclastic activitiesare involved in bone cancer pain and cause elevated levels of serum bone alkaline phosphatase (BAP) and carboxyterminal pyridlinoline cross-linked telopeptide of type 1 collagen (ICTP). Transient receptor potential channels, vanilloid subfamily member 1 (TRPV1), and TRPA1, and TRPV4 are also involved persistent pain. Our pilot studies showed that an herbal formula, TLSJ, which has been used clinically, alleviated bone cancer pain in patients and in a rat model. The objective of the proposal is to evaluate the efficacy and safety of TLSJ on cancer pain and explore its mechanisms in male and female rat models. We hypothesize that external applications of a TLSJ gel will inhibit cancer pain by suppressing osteoclast activities, evidenced by decrasig levels of serum BAP and ICTA, and TRP channel expression in dorsal root ganglia (DRG). The three aims are: Aim 1 a) To determine the effect of TLSJ Gel on cancer-induced pain in male and female rat models of bone cancer pain. Spontaneious pain, thermal hyperalgesia and mechanical hyperalgesia/allodyna will be determined following herb treatment. b) To determine the safety of TLSJ. Possible adverse effects will be studied by monitoring the animals for behavioral changes, and the toxicity of the formula will be determined by biochemical assay and histological examination. Aim 2. To investigate effects of TLSJ Gel on osteoclasic activity and BAP and ICTP levels during cancer pain. Bone osteeoclastic activity will be hisologically examined. Serum BAP and ICTP will be measured using ELISA. Aim e. To investigate effects of TLSJ Gel on TRP channel expression. TRPV1, TRPA1 and TRPV4 antagonists will be used to characterize TRP involvement in bone cancer pain. DRG expression of the three channels will be examined by immunohistochemical staining. The success of the experiments will provide preliminary data for designing clinical trials to study the effects of Chinese herbs on persistent cancer pain. This will facilitate the development of effective and safe alternative/complementary treatment for cancer pain. PUBLIC HEALTH RELEVANCE: Pain occurs frequently incancerpatients and has not been controlled adequately. Acupuncture has been used for millennia to treat pain. This study will evaluate the effects and mechanisms of an herb formula Tongluo Sanjie (TLSJ) on such pain in rat models. The success of the proposed study will greatly advance the management of cancer pain.

描述（由申请人提供）：拟定的关于中草药配方治疗癌症疼痛的机制的国际研究是我们正在进行的由NIH资助的父母赠款的扩展，P01-AT 002605（9/2005 - 8/2010 10）和R21 AT 004113（2/1/08 - 1/31/10）。主要研究者Lao博士是P01研究针灸对持续性炎性疼痛的作用机制和C 0-I研究针灸对癌症相关疼痛的作用的项目负责人。该项目将与中国上海长征医院（CZ）的徐玲博士合作进行。疼痛是与癌症相关的最常见和最令人恐惧的症状之一，目前尚未得到充分控制。几千年来，中国草药一直被用来治疗各种疾病，包括疼痛。Lao博士和他的团队一直在研究癌症引起的疼痛，他的合作者Ling Xu博士一直在研究中药对癌症相关疾病的影响，包括疼痛。以往的研究表明，骨细胞活性参与了骨癌疼痛，并导致血清骨碱性磷酸酶（BAP）和1型胶原羧基末端吡啶啉交联端肽（ICTP）水平升高。瞬时受体电位通道，香草酸亚家族成员1（TRPV 1），TRPA 1和TRPV 4也参与持续性疼痛。我们的初步研究表明，一个草药配方，TLSJ，这已被用于临床，减轻骨癌疼痛的患者和大鼠模型。本研究的目的是在雄性和雌性大鼠模型上评价TLSJ治疗癌症疼痛的有效性和安全性，并探讨其作用机制。我们假设TLSJ凝胶的外部应用将通过抑制破骨细胞活性来抑制癌症疼痛，这通过血清BAP和ICTA水平的下降以及背根神经节（DRG）中TRP通道表达来证明。目的1 a）确定TLSJ凝胶对骨癌疼痛的雄性和雌性大鼠模型中的癌诱发疼痛的作用。自发性疼痛、热痛觉过敏和机械性痛觉过敏/异常性疼痛将在草药治疗后测定。B）确定TLSJ的安全性。通过监测动物的行为变化来研究可能的不良反应，并通过生化分析和组织学检查来确定配方的毒性。目标2.目的：观察TLSJ凝胶对癌痛时破骨细胞活性及BAP、ICTP水平的影响。将对骨的骨细胞活性进行组织学检查。将使用ELISA测量血清BAP和ICTP。瞄准E研究TLSJ凝胶对TRP通道表达的影响。TRPV 1、TRPA 1和TRPV 4拮抗剂将用于表征TRP参与骨癌疼痛的特征。将通过免疫组织化学染色检查三个通道的DRG表达。实验的成功将为设计临床试验研究中药对持续性癌痛的影响提供初步数据。这将有助于开发有效和安全的癌症疼痛替代/补充治疗方法。 公共卫生相关性：疼痛经常发生在癌症患者身上，并且没有得到充分的控制.针灸治疗疼痛已有数千年的历史。本研究旨在探讨通络散结方对大鼠痛模型的作用及其机制。这项研究的成功将大大推进癌症疼痛的管理。

项目成果

Topical treatment with Tong-Luo-San-Jie gel alleviates bone cancer pain in rats.

用Tong-luo-san-jie凝胶局部治疗可减轻大鼠的骨癌疼痛。

• DOI: 10.1016/j.jep.2012.08.026
• 发表时间: 2012-10-11
• 期刊: JOURNAL OF ETHNOPHARMACOLOGY
• 影响因子: 5.4
• 作者: Wang, Juyong;Zhang, Ruixin;Dong, Changsheng;Jiao, Liying;Xu, Ling;Liu, Jiyong;Wang, Zhengtao;Ying, Qi Liang Mao;Fong, Harry;Lao, Lixing
• 通讯作者: Lao, Lixing